Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	inclusion criteria: 1. symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate \>22 per minute). 2. nasopharyngeal rt-pcr positive sars-cov-2 3. age 20-50 years 4. bmi 18-28 kg/m2 5. informed consent	inclusion criteria: 1. symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate \>22 per minute). 2. nasopharyngeal rt-pcr positive sars-cov-2 3. age 20-50 years 4. bmi 18-28 kg/m2 5. informed consent
Nov. 16, 2021, 6:30 p.m.	usa	inclusion criteria: symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate >22 per minute). nasopharyngeal rt-pcr positive sars-cov-2 age 20-50 years bmi 18-28 kg/m2 informed consent	inclusion criteria: symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate >22 per minute). nasopharyngeal rt-pcr positive sars-cov-2 age 20-50 years bmi 18-28 kg/m2 informed consent
Oct. 26, 2020, 11:31 p.m.	usa	inclusion criteria: 1. symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate >22 per minute). 2. nasopharyngeal rt-pcr positive sars-cov-2 3. age 20-50 years 4. bmi 18-28 kg/m2 5. informed consent	inclusion criteria: 1. symptomatic patients: defined as fever (temperature greater than 100 degree f), cough, or shortness of breath (respiratory rate >22 per minute). 2. nasopharyngeal rt-pcr positive sars-cov-2 3. age 20-50 years 4. bmi 18-28 kg/m2 5. informed consent